Scientific reports · 2018
Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chang Tian-Jong, Zheng Cai-Mei, Wu Mei-Yi, Chen Tzu-Ting, Wu Yun-Chun, Wu Yi-Lien, Lin Hsin-Ting, Zheng Jing-Quan, Chu Nain-Feng, Lin Yu-Me, Su Sui-Lung, Lu Kuo-Cheng, Chen Jin-Shuen, Sung Fung-Chang, Lee Chien-Te, Yang Yu, Hwang Shang-Jyh, Wang Ming-Cheng, Hsu Yung-Ho, Chiou Hung-Yi, Kao Senyeong, Lin Yuh-Feng
Аннотация
This study investigated the characteristics of patients with different chronic kidney disease (CKD) stages according to various body mass index (BMI) categories and determined the influence of BMI in renal function deterioration. We conducted a multicenter, longitudinal cohort study based on the Epidemiology and Risk Factors Surveillance of CKD project (2008-2013) and National Health Insurance Research Database (2001-2013). A total of 7357 patients with CKD aged 20-85 years from 14 hospitals were included in the study. A higher male sex, diabetes mellitus (DM) and hypertension were noted among overweight and obese CKD patients, while more cancer prevalence was noted among underweight CKD patients. Charlson comorbidity index was significantly higher and correlated with BMI among late CKD patients. Patients with BMI < 18.5 kg/m2 exhibited non-significantly higher events of eGFR decline events in both early and late CKD stages than other BMI groups. BMI alone is not a determinant of CKD progression among our Taiwanese CKD patients. Obesity should be re-defined and body weight manipulation should be individualized in CKD patients.